Supplying take home naloxone without a prescription
A guide to the legislation enabling drug services and others to supply take home naloxone without a prescription to save a life in an emergency.
A guide to the legislation enabling drug services and others to supply take home naloxone without a prescription to save a life in an emergency.
New Vision Bradford has launched a groundbreaking campaign to increase the number of people carrying naloxone, a life-saving medication that reverses opioid overdoses. At the heart of the ‘You Can Save a Life’ campaign is a stunning new film that illustrates the power of naloxone to prevent deaths. The film aims to challenge misconceptions, raise awareness, and inspire individuals to carry a naloxone kit – potentially saving lives in their communities.
This short report describes the purpose, process and meetings of the Naloxone Reporting Short Life Working Group (SLWG). This report also describes the recommendations of the SLWG and outlines the next stage in this change process, where organisations will review these findings and respond to them.
EuroNPUD have released their Technical Briefing on Peer to Peer Naloxone which includes information, case studies and guidance on developing Peer2Peer models of naloxone distribution.
A new report published by SDF shows the evaluation of the peer-to-peer naloxone programme within three pilot areas: one prison, one rural, one urban. The project aimed to establish, embed, and support high quality peer supply of naloxone as a core service across Scotland and ensure those involved in peer supply have an active voice in delivery of naloxone and other harm reduction interventions, including the sharing and promotion of good practice.
The Advisory Council of the Misuse of Drugs (ACMD) has reviewed the evidence on the provision and availability of naloxone in the UK, a medicine which can temporarily reverse the effects of opioids and is used as an emergency treatment for people who overdose on these drugs. The findings of this review, and recommendations to optimise the use of naloxone are presented in this report.